肝移植等待名单构成的变化：直接抗病毒药物时代之前与之后。尼瓜尔达医院的经验。 - Suppr | 超能文献

Change of liver transplantation list composition: Pre versus post direct-acting antivirals era. The Niguarda Hospital experience.

作者信息

Viganò Raffaella, Mazzarelli Chiara, Alberti Alberto Battista, Perricone Giovanni

机构信息

Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

出版信息

Dig Liver Dis. 2017 Mar;49(3):317. doi: 10.1016/j.dld.2017.01.145. Epub 2017 Jan 19.

DOI:10.1016/j.dld.2017.01.145

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Change of liver transplantation list composition: Pre versus post direct-acting antivirals era. The Niguarda Hospital experience.肝移植等待名单构成的变化：直接抗病毒药物时代之前与之后。尼瓜尔达医院的经验。

Dig Liver Dis. 2017 Mar;49(3):317. doi: 10.1016/j.dld.2017.01.145. Epub 2017 Jan 19.

2

Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.肝移植受者中丙型肝炎病毒直接作用抗病毒药物的移植前与移植后治疗：更多待解决的问题

Exp Clin Transplant. 2017 Feb;15(Suppl 1):1-5. doi: 10.6002/ect.mesot2016.L19.

3

Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.

J Hepatol. 2018 Oct;69(4):966-968. doi: 10.1016/j.jhep.2018.06.011. Epub 2018 Jul 7.

4

Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.利与弊：使用丙型肝炎病毒感染者的器官 - 在直接作用抗病毒时代的修订。

J Hepatol. 2016 Jan;64(1):226-31. doi: 10.1016/j.jhep.2015.09.002. Epub 2015 Sep 12.

5

Treatment of patients with hepatitis C virus on the waiting list.

Liver Transpl. 2003 Nov;9(11):S90-4. doi: 10.1053/jlts.2003.50247.

6

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.国际肝移植学会关于肝移植候选者丙型肝炎管理的共识声明

Transplantation. 2017 May;101(5):945-955. doi: 10.1097/TP.0000000000001708.

7

Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.代偿期肝硬化患者的治疗选择，移植前后。

J Hepatol. 2014 Nov;61(1 Suppl):S120-31. doi: 10.1016/j.jhep.2014.07.020. Epub 2014 Nov 3.

8

Management of HCV transplant patients with triple therapy.丙型肝炎病毒移植患者三联疗法的管理。

Liver Int. 2014 Feb;34 Suppl 1:46-52. doi: 10.1111/liv.12406.

9

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.

Liver Transpl. 2017 Dec;23(12):1628-1629. doi: 10.1002/lt.24962.

10

Common issues in the management of patients in the waiting list and after liver transplantation.等待名单上的患者及肝移植后患者管理中的常见问题。

Dig Liver Dis. 2017 Mar;49(3):241-253. doi: 10.1016/j.dld.2016.12.027. Epub 2016 Dec 31.

引用本文的文献

1

Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?肝细胞癌患者肝移植的选择：预期肿瘤学生存的阈值是否应降低？

Transplant Direct. 2019 May 29;5(6):e459. doi: 10.1097/TXD.0000000000000904. eCollection 2019 Jun.

2

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.自直接作用抗病毒药物问世以来，丙型肝炎病毒相关肝硬化作为肝移植适应证的比例有所下降：一项单中心研究。

World J Gastroenterol. 2018 Oct 14;24(38):4403-4411. doi: 10.3748/wjg.v24.i38.4403.